Oxfam project on role of institutional investors in poverty reduction – report from workshop on private equity investing in developing countries
All components of this story
Author: Helena Viňes Fiestas, Oxfam lead on BRBW and Rory Sullivan, Investment community lead on BRBW
On 27 January 2010, the sixth Better Returns in a Better World workshop took place…in London. It focused on the role of institutional investors when investing in Private Equity (PE) funds that invest in developing countries…Responsible private equity investment…can contribute to building sustainable businesses that provide decent work…and support sustainable development. For PE investment in developing countries to be sustainable a focus on responsible Environmental, Social and Governance (ESG) practices is required – often beyond compliance with local laws. Such ESG practices can bring about benefits for local communities, fund managers, investors and the businesses themselves…
Author: Marie Rosencrantz and James McVeigh, CDC; Helena Viñes Fiestas, Oxfam and BRBW; Rory Sullivan, BRBW
Reflecting the overarching objectives of the Better Returns in a Better World project…the…workshop will seek to answer the following questions: To what extent is the responsible investment framework provided by the UN Principles for Responsible investment...(a) relevant, (b) applicable to private equity? What should investors expect private equity firms to have in place in terms of: (a) policies, (b) management processes, (c) reporting? What are the implications of the governance relationships between institutional investors and private equity firms? How can institutional investors measure the ESG performance of private equity firms? Can institutional investors use ESG criteria to guide their choice of private equity firm?
Author: Marie Rosencrantz and James McVeigh, CDC; Ritu Kumar, Actis
The roundtable debated the role of institutional investors when investing in Private Equity (PE) funds that invest in developing countries…To enrich and frame the discussion CDC and Actis have written the following succinct paper that summarises CDC experiences in Sub-Saharan Africa, and Actis learning from their operations in India. [refers to Shelys Pharmaceuticals]